Provisional matrix: A role for versican and hyaluronan

Matrix Biology

Volumn 60-61, Issue , 2017, Pages 38-56

  Wight, Thomas N ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Development; Extracellular matrix; Glycocaylx; Hyaluronan; Leukocytes; Remodeling; Versican

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; HYALADHERIN; HYALURONIC ACID; UNCLASSIFIED DRUG; VERSICAN; COLLAGEN; PLATELET DERIVED GROWTH FACTOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; MALIGNANT NEOPLASM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VISCOELASTICITY; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LEIOMYOSARCOMA; METABOLISM; MOUSE; PATHOLOGY; UTERUS CANCER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; LEIOMYOSARCOMA; MICE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA; UTERINE NEOPLASMS; VERSICANS;

EID: 85008158288     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.12.001     Document Type: Review

References (213)

1. Bissell, M., Hall, H.G., Parry, G., How does the extracellular matrix control gene expression?. J. Theor. Biol. 99 (1982), 31–68.
2. Hay, E.D., Cell Biology of Extracellular Matrix. 1991, Plenum Press, New York.
3. Järveläinen, H., Sainio, A., Koulu, M., Wight, T.N., Penttinen, R., Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol. Rev. 61 (2009), 198–223.
4. Merrilees, M.J., Wight, T.N., Targeting the matrix: potential benefits for versican therapeutics. http://www.elsevierblogs.com/currentcomments/?p=519, 2012.
5. Venning, F.A., Wullkopf, L., Erler, J.T., Targeting ECM disrupts cancer progression. Front. Oncol., 5, 2015, 224.
6. Clark, R.A.F., Cutaneous tissue repair: basic biologic considerations. J. Am. Acad. Derm. 13 (1985), 701–725.
7. Singer, A.J., Clark, R.A., Cutaneous wound healing. N. Engl. J. Med. 341 (1999), 738–746.
8. Clark, R.A., Basics of cutaneous wound repair. J. Dermatol. Surg. Oncol. 19 (1993), 693–706.
9. Hay, E.D., Development of the vertebrate cornea. Int. Rev. Cytol. 63 (1980), 263–322.
10. Toole, B.P., Morphogenetic role of glycosaminoglycans (acid mucopolysaccharides) in brain and other tissues. Barondes, S.H., (eds.) Neuronal Recognition, 1976, Plenum Press, New York, 275–329.
11. Weigel, P.H., Fuller, G.M., LeBoeuf, R.D., A model for the role of hyaluronic acid and fibrinogen in the early events of inflammatory response and wound healing. J. Theor. Biol. 119 (1986), 219–234.
12. Guarino, M., Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell Biol. 39 (2007), 2153–2160.
13. Yamada, K.M., Clark, R.A.F., Provisional matrix. Clark, R.A.F., (eds.) The Molecular and Cellular Biology of Wound Repair, 1996, Plenum Press, New York, 51–93.
14. Schultz, G.S., Wysocki, A., Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 17 (2009), 153–162.
15. Johnson, P.Y., Potter-Perigo, S., Gooden, M.D., Vernon, R.B., Wight, T.N., Decorin synthesized by arterial smooth muscle cells is retained in fibrin gels and modulates fibrin contraction. J. Cell. Biochem. 101 (2007), 281–294.
16. Oksala, O., Salo, T., Tammi, R., Hakkinen, L., Jalkanen, M., Inki, P., Larjava, H., Expression of proteoglycans and hyaluronan during wound healing. J. Histochem. Cytochem. 43 (1995), 125–135.
17. Pierce, G.F., Berg, J.V., Rudolph, R., Tarpley, J., Mustoe, T.A., Platelet-derived growth factor-BB and transforming growth factor beta1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am. J. Pathol. 138 (1991), 629–646.
18. Maytin, E.V., Hyaluronan: more than just a wrinkle filler. Glycobiology 26 (2016), 553–559.
19. Brown, L.F., Dubin, D., Lavigne, L., Logan, B., Dvorak, H.F., Van De Water, L., Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am. J. Pathol. 142 (1993), 793–801.
20. Dobaczewski, M., Gonzalez-Quesada, C., Frangogiannis, N.G., The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 48 (2010), 504–511.
21. Weigel, P.H., Hascall, V.C., Tammi, M., Hyaluronan synthases. J. Biol. Chem. 272 (1997), 13997–14000.
22. Tammi, M.I., Day, A.J., Turley, E.A., Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277 (2002), 4581–4584.
23. Weigel, P.H., DeAngelis, P.L., Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J. Biol. Chem. 282 (2007), 36777–36781.
24. Itano, N., Kimata, K., Mammalian hyaluronan synthases. IUBMB Life 54 (2002), 195–199.
25. Hascall, V.C., Heinegård, D.K., Wight, T.N., Proteoglycans: metabolism and pathology. Hay, E.D., (eds.) Cell Biology of Extracellular Matrix, 1991, Plenum Press, New York, 149–175.
26. Wight, T.N., Heinegård, D.K., Hascall, V.C., Proteoglycans: structure and function. Hay, E.D., (eds.) Cell Biology of Extracellular Matrix, 1991, Plenum Press, New York, 45–78.
27. Stern, R., Jedrzejas, M.J., Hyaluronidases: their genomics, structures, and mechanisms of action. Chem. Rev. 106 (2006), 818–839.
28. Stern, R., Kogan, G., Jedrzejas, M.J., Soltes, L., The many ways to cleave hyaluronan. Biotechnol. Adv. 25 (2007), 537–557.
29. Petrey, A.C., de la Motte, C.A., Hyaluronan, a crucial regulator of inflammation. Front. Immunol., 5, 2014, 101.
30. Toole, B.P., Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4 (2004), 528–539.
31. Evanko, S.P., Tammi, M.I., Tammi, R.H., Wight, T.N., Hyaluronan-dependent pericellular matrix. Adv. Drug Deliv. Rev. 59 (2007), 1351–1365.
32. de la Motte, C.A., Hascall, V.C., Drazba, J., Bandyopadhyay, S.K., Strong, S.A., Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-α-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 163 (2003), 121–133.
33. Bollyky, P.L., Bogdani, M., Bollyky, J.B., Hull, R.L., Wight, T.N., The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr. Diab. Rep. 12 (2012), 471–480.
34. Toole, B.P., Hyaluronan promotes the malignant phenotype. Glycobiology 12 (2002), 37R–42R.
35. Toole, B.P., Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin. Cancer Res. 15 (2009), 7462–7468.
36. Toole, B.P., Slomiany, M.G., Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist. Updat. 11 (2008), 110–121.
37. Toole, B.P., Wight, T.N., Tammi, M.I., Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277 (2002), 4593–4596.
38. Misra, S., Heldin, P., Hascall, V.C., Karamanos, N.K., Skandalis, S.S., Markwald, R.R., Ghatak, S., Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 278 (2011), 1429–1443.
39. McAtee, C.O., Berkebile, A.R., Elowsky, C.G., Fangman, T., Barycki, J.J., Wahl, J.K. 3rd, Khalimonchuk, O., Naslavsky, N., Caplan, S., Simpson, M.A., Hyaluronidase Hyal1 increases tumor cell proliferation and motility through accelerated vesicle trafficking. J. Biol. Chem. 290 (2015), 13144–13156.
40. LeBaron, R.G., Zimmermann, D.R., Ruoslahti, E., Hyaluronate binding properties of versican. J. Biol. Chem. 267 (1992), 10003–10010.
41. Iozzo, R.V., Naso, M.F., Cannizzaro, L.A., Wasmuth, J.J., McPherson, J.D., Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12–5q14). Genomics 14 (1992), 845–851.
42. Naso, M.F., Zimmermann, D.R., Iozzo, R.V., Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J. Biol. Chem. 269 (1994), 32999–33008.
43. Zimmermann, D., Versican. Iozzo, R., (eds.) Proteoglycans: Structure, Biology and Molecular Interactions, 2000, Marcel Dekker, Inc., New York, 327–341.
44. Wight, T.N., Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14 (2002), 617–623.
45. Wight, T.N., Kang, I., Merrilees, M.J., Versican and the control of inflammation. Matrix Biol. 35 (2014), 152–161.
46. Zako, M., Shinomura, T., Ujita, M., Ito, K., Kimata, K., Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J. Biol. Chem. 270 (1995), 3914–3918.
47. Zimmermann, D.R., Dours-Zimmermann, M.T., Extracellular matrix of the central nervous system: from neglect to challenge. Histochem. Cell Biol. 130 (2008), 635–653.
48. Cardoso, L.E., Little, P.J., Ballinger, M.L., Chan, C.K., Braun, K.R., Potter-Perigo, S., Bornfeldt, K.E., Kinsella, M.G., Wight, T.N., Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. J. Biol. Chem. 285 (2010), 6987–6995.
49. Schönherr, E., Järveläinen, H.T., Sandell, L.J., Wight, T.N., Effects of platelet-derived growth factor and transforming growth factor-β 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266 (1991), 17640–17647.
50. Kenagy, R.D., Plaas, A.H., Wight, T.N., Versican degradation and vascular disease. Trends Cardiovasc. Med. 16 (2006), 209–215.
51. Apte, S.S., A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J. Biol. Chem. 284 (2009), 31493–31497.
52. McCulloch, D.R., Nelson, C.M., Dixon, L.J., Silver, D.L., Wylie, J.D., Lindner, V., Sasaki, T., Cooley, M.A., Argraves, W.S., Apte, S.S., ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev. Cell 17 (2009), 687–698.
53. Chang, M.Y., Tanino, Y., Vidova, V., Kinsella, M.G., Chan, C.K., Johnson, P.Y., Wight, T.N., Frevert, C.W., A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 34 (2014), 1–12.
54. Sotoodehnejadnematalahi, F., Staples, K.J., Chrysanthou, E., Pearson, H., Ziegler-Heitbrock, L., Burke, B., Mechanisms of hypoxic up-regulation of versican gene expression in macrophages. PLoS One, 10, 2015, e0125799.
55. Wight, T., Toole, B., Hascall, V., Hyaluronan and the aggregating proteoglycans. Mecham, R., (eds.) The Extracellular Matrix: an Overview, 2011, Springer, Heidelberg, 147–195.
56. Blundell, C.D., Almond, A., Mahoney, D.J., DeAngelis, P.L., Campbell, I.D., Day, A.J., Towards a structure for a TSG-6.hyaluronan complex by modeling and NMR spectroscopy: insights into other members of the link module superfamily. J. Biol. Chem. 280 (2005), 18189–18201.
57. Blundell, C.D., Mahoney, D.J., Almond, A., DeAngelis, P.L., Kahmann, J.D., Teriete, P., Pickford, A.R., Campbell, I.D., Day, A.J., The link module from ovulation- and inflammation-associated protein TSG-6 changes conformation on hyaluronan binding. J. Biol. Chem. 278 (2003), 49261–49270.
58. Day, A.J., de la Motte, C.A., Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol. 26 (2005), 637–643.
59. Day, A.J., Prestwich, G.D., Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277 (2002), 4585–4588.
60. Day, A.J., Sheehan, J.K., Hyaluronan: polysaccharide chaos to protein organisation. Curr. Opin. Struct. Biol. 11 (2001), 617–622.
61. Yang, B., Yang, B.L., Savani, R.C., Turley, E.A., Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13 (1994), 286–296.
62. Merrilees, M.J., Zuo, N., Evanko, S.P., Day, A.J., Wight, T.N., G1 domain of versican regulates hyaluronan organization and the phenotype of cultured human dermal fibroblasts. J. Histochem. Cytochem. 64 (2016), 353–363.
63. Wight, T.N., Merrilees, M.J., Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94 (2004), 1158–1167.
64. Hinek, A., Braun, K.R., Liu, K., Wang, Y., Wight, T.N., Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am. J. Pathol. 164 (2004), 119–131.
65. Hwang, J.Y., Johnson, P.Y., Braun, K.R., Hinek, A., Fischer, J.W., O'Brien, K.D., Starcher, B., Clowes, A.W., Merrilees, M.J., Wight, T.N., Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury. Am. J. Pathol. 173 (2008), 1919–1928.
66. Kang, I., Barth, J.L., Sproul, E.P., Yoon, D.W., Braun, K.R., Argraves, W.S., Wight, T.N., Expression of V3 versican by rat arterial smooth muscle cells promotes differentiated and anti-inflammatory phenotypes. J. Biol. Chem. 290 (2015), 21629–21641.
67. Kang, I., Yoon, D.W., Braun, K.R., Wight, T.N., Expression of versican V3 by arterial smooth muscle cells alters TGFβ-, EGF-, and NFκB-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion. J. Biol. Chem. 289 (2014), 15393–15404.
68. Merrilees, M.J., Beaumont, B.W., Braun, K.R., Thomas, A.C., Kang, I., Hinek, A., Passi, A., Wight, T.N., Neointima formed by arterial smooth muscle cells expressing versican variant v3 is resistant to lipid and macrophage accumulation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 1309–1316.
69. Merrilees, M.J., Lemire, J.M., Fischer, J.W., Kinsella, M.G., Braun, K.R., Clowes, A.W., Wight, T.N., Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ. Res. 90 (2002), 481–487.
70. Potter-Perigo, S., Johnson, P.Y., Evanko, S.P., Chan, C.K., Braun, K.R., Wilkinson, T.S., Altman, L.C., Wight, T.N., Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am. J. Respir. Cell Mol. Biol. 43 (2010), 109–120.
71. Lauer, M.E., Aytekin, M., Comhair, S.A., Loftis, J., Tian, L., Farver, C.F., Hascall, V.C., Dweik, R.A., Modification of hyaluronan by heavy chains of inter-alpha-inhibitor in idiopathic pulmonary arterial hypertension. J. Biol. Chem. 289 (2014), 6791–6798.
72. Lauer, M.E., Cheng, G., Swaidani, S., Aronica, M.A., Weigel, P.H., Hascall, V.C., Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells. J. Biol. Chem. 288 (2013), 423–431.
73. Lauer, M.E., Glant, T.T., Mikecz, K., DeAngelis, P.L., Haller, F.M., Husni, M.E., Hascall, V.C., Calabro, A., Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6. J. Biol. Chem. 288 (2013), 205–214.
74. Milner, C., Tongsoongnoen, W., Rugg, M., Day, A., The molecular basis of inter-alpha-inhibitor heavy chain transfer on to hyaluronan. Biochem. Soc. Trans. 35 (2007), 672–676.
75. Csoka, A.B., Stern, R., Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology 23 (2013), 398–411.
76. Lauer, M.E., Dweik, R.A., Garantziotis, S., Aronica, M.A., The rise and fall of hyaluronan in respiratory diseases. Int. J. Cell. Biol., 2015, 2015, 712507.
77. Coulson-Thomas, V.J., Gesteira, T.F., Hascall, V., Kao, W., Umbilical cord mesenchymal stem cells suppress host rejection: the role of the glycocalyx. J. Biol. Chem. 289 (2014), 23465–23481.
78. Avnet, S., Cortini, M., Role of pericellular matrix in the regulation of cancer stemness. Stem Cell Rev. 12 (2016), 464–475.
79. Evanko, S.P., Angello, J.C., Wight, T.N., Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999), 1004–1013.
80. Evanko, S.P., Johnson, P.Y., Braun, K.R., Underhill, C.B., Dudhia, J., Wight, T.N., Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch. Biochem. Biophys. 394 (2001), 29–38.
81. Riessen, R., Wight, T.N., Pastore, C., Henley, C., Isner, J.M., Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93 (1996), 1141–1147.
82. Schönherr, E., Kinsella, M.G., Wight, T.N., Genistein selectively inhibits platelet-derived growth factor stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch. Biochem. Biophys. 339 (1997), 353–361.
83. Clarris, B.J., Fraser, J.R., On the pericellular zone of some mammalian cells in vitro. Exp. Cell Res. 49 (1968), 181–193.
84. Knudson, C.B., Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J. Cell Biol. 120 (1993), 825–834.
85. Huang, Y., Askew, E.B., Knudson, C.B., Knudson, W., CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. Matrix Biol. 56 (2016), 74–94.
86. Szabo, A., Melchionda, M., Nastasi, G., Woods, M.L., Campo, S., Perris, R., Mayor, R., In vivo confinement promotes collective migration of neural crest cells. J. Cell Biol. 213 (2016), 543–555.
87. Hattori, N., Carrino, D.A., Lauer, M.E., Vasanji, A., Wylie, J.D., Nelson, C.M., Apte, S.S., Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J. Biol. Chem. 286 (2011), 34298–34310.
88. du Cros, D.L., LeBaron, R.G., Couchman, J.R., Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J. Invest. Dermatol. 105 (1995), 426–431.
89. Kishimoto, J., Ehama, R., Wu, L., Jiang, S., Jiang, N., Burgeson, R.E., Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 7336–7341.
90. Russell, D., Salustri, A., Extracellular matrix of the cumulus-oocyte complex. Semin. Reprod. Med. 24 (2006), 217–227.
91. Russell, D.L., Ochsner, S.A., Hsieh, M., Mulders, S., Richards, J.S., Hormone-regulated expression and localization of versican in the rodent ovary. Endocrinology 144 (2003), 1020–1031.
92. Ruscheinsky, M., De la Motte, C., Mahendroo, M., Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence. Matrix Biol. 27 (2008), 487–497.
93. Shinomura, T., Nishida, Y., Ito, K., Kimata, K., cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationship to versican. J. Biol. Chem. 268 (1993), 14461–14469.
94. Shinomura, T., Jensen, K.L., Yamagata, M., Kimata, K., Solursh, M., The distribution of mesenchyme proteoglycan (PG-M) during wing bud outgrowth. Anat. Embryol. (Berl.) 181 (1990), 227–233.
95. Stigson, M., Lofberg, J., Kjellen, L., Reduced epidermal expression of a PG-M/versican-like proteoglycan in embryos of the white mutant axolotl. Exp. Cell Res. 236 (1997), 57–65.
96. Stigson, M., Lofberg, J., Kjellen, L., PG-M/versican-like proteoglycans are components of large disulfide- stabilized complexes in the axolotl embryo. J. Biol. Chem. 272 (1997), 3246–3253.
97. Perris, R., Johansson, S., Inhibition of neural crest cell migration by aggregating chondroitin sulfate proteoglycans is mediated by their hyaluronan-binding region. Dev. Biol. 137 (1990), 1–12.
98. Perris, R., Lofberg, J., Fallstrom, C., von Boxberg, Y., Olsson, L., Newgreen, D.F., Structural and compositional divergencies in the extracellular matrix encountered by neural crest cells in the white mutant axolotl embryo. Development 109 (1990), 533–551.
99. Perris, R., Perissinotto, D., Role of the extracellular matrix during neural crest cell migration. Mech. Dev. 95 (2000), 3–21.
100. Perris, R., Perissinotto, D., Pettway, Z., Bronner-Fraser, M., Morgelin, M., Kimata, K., Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration. FASEB J. 10 (1996), 293–301.
101. Choudhary, M., Zhang, X., Stojkovic, P., Hyslop, L., Anyfantis, G., Herbert, M., Murdoch, A.P., Stojkovic, M., Lako, M., Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization. Stem Cells 25 (2007), 3045–3057.
102. Nairn, A.V., Kinoshita-Toyoda, A., Toyoda, H., Xie, J., Harris, K., Dalton, S., Kulik, M., Pierce, J.M., Toida, T., Moremen, K.W., Linhardt, R.J., Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J. Proteome Res. 6 (2007), 4374–4387.
103. Shukla, S., Nair, R., Rolle, M.W., Braun, K.R., Chan, C.K., Johnson, P.Y., Wight, T.N., McDevitt, T.C., Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J. Histochem. Cytochem. 58 (2010), 345–358.
104. Chan, C.K., Rolle, M.W., Potter-Perigo, S., Braun, K.R., Van Biber, B.P., Laflamme, M.A., Murry, C.E., Wight, T.N., Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan. J. Cell. Biochem. 111 (2010), 585–596.
105. Mjaatvedt, C.H., Yamamura, H., Capehart, A.A., Turner, D., Markwald, R.R., The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 202 (1998), 56–66.
106. Yamamura, H., Zhang, M., Markwald, R.R., Mjaatvedt, C.H., A heart segmental defect in the anterior–posterior axis of a transgenic mutant mouse. Dev. Biol. 186 (1997), 58–72.
107. Camenisch, T.D., Spicer, A.P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M.L., Calabro, A. Jr., Kubalak, S., Klewer, S.E., McDonald, J.A., Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106 (2000), 349–360.
108. Kern, C.B., Norris, R.A., Thompson, R.P., Argraves, W.S., Fairey, S.E., Reyes, L., Hoffman, S., Markwald, R.R., Mjaatvedt, C.H., Versican proteolysis mediates myocardial regression during outflow tract development. Dev. Dyn. 236 (2007), 671–683.
109. Kern, C.B., Twal, W.O., Mjaatvedt, C.H., Fairey, S.E., Toole, B.P., Iruela-Arispe, M.L., Argraves, W.S., Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev. Dyn. 235 (2006), 2238–2247.
110. Kern, C.B., Wessels, A., McGarity, J., Dixon, L.J., Alston, E., Argraves, W.S., Geeting, D., Nelson, C.M., Menick, D.R., Apte, S.S., Reduced versican cleavage due to Adamts9 haplo insufficiency is associated with cardiac and aortic anomalies. Matrix Biol. 29 (2010), 304–316.
111. Chung, I.M., Gold, H.K., Schwartz, S.M., Ikari, Y., Reidy, M.A., Wight, T.N., Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J. Am. Coll. Cardiol. 40 (2002), 2072–2081.
112. Farb, A., Kolodgie, F.D., Hwang, J.Y., Burke, A.P., Tefera, K., Weber, D.K., Wight, T.N., Virmani, R., Extracellular matrix changes in stented human coronary arteries. Circulation 110 (2004), 940–947.
113. Wight, T.N., Lara, S., Reissen, R., LeBaron, R., Isner, J., Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am. J. Pathol. 151 (1997), 963–973.
114. Matsuura, R., Isaka, N., Imanaka-Yoshida, K., Yoshida, T., Sakakura, T., Nakano, T., Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. J. Pathol. 180 (1996), 311–316.
115. Wight, T., The vascular extracellular matrix. Fuster, V., Topol, E., Nabel, E., (eds.) Atherothrombosis and Coronary Artery Disease, 2005, Lippincott Williams and Wilkins, Philadelphia, 421–437.
116. Kashima, Y., Takahashi, M., Shiba, Y., Itano, N., Izawa, A., Koyama, J., Nakayama, J., Taniguchi, S., Kimata, K., Ikeda, U., Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One, 8, 2013, e58760.
117. Kiene, L.S., Homann, S., Suvorava, T., Rabausch, B., Muller, J., Kojda, G., Kretschmer, I., Twarock, S., Dai, G., Deenen, R., Hartwig, S., Lehr, S., Kohrer, K., Savani, R.C., Grandoch, M., Fischer, J.W., Deletion of hyaluronan synthase 3 inhibits neointimal hyperplasia in mice. Arterioscler. Thromb. Vasc. Biol. 36 (2016), e9–e16.
118. Geary, R.L., Nikkari, S.T., Wagner, W.D., Williams, J.K., Adams, M.R., Dean, R.H., Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J. Vasc. Surg. 27 (1998), 96–106.
119. Swedberg, S.H., Brown, B.G., Sigley, R., Wight, T.N., Gordon, D., Nicholls, S.C., Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80 (1989), 1726–1736.
120. de la Motte, C.A., Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 301 (2011), G945–G949.
121. Aytekin, M., Comhair, S.A., de la Motte, C., Bandyopadhyay, S.K., Farver, C.F., Hascall, V.C., Erzurum, S.C., Dweik, R.A., High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 295 (2008), L789–L799.
122. Chang, Y.T., Chan, C.K., Eriksson, I., Johnson, P.Y., Cao, X., Westoo, C., Norvik, C., Andersson-Sjoland, A., Westergren-Thorsson, G., Johansson, S., Hedin, U., Kjellen, L., Wight, T.N., Tran-Lundmark, K., Versican accumulates in vascular lesions in pulmonary arterial hypertension. Pulm. Circ. 6 (2016), 347–359.
123. Keire, P.A., Bressler, S.L., Lemire, J.M., Edris, B., Rubin, B.P., Rahmani, M., McManus, B.M., van de Rijn, M., Wight, T.N., A role for versican in the development of leiomyosarcoma. J. Biol. Chem. 289 (2014), 34089–34103.
124. Ricciardelli, C., Russell, D.L., Ween, M.P., Mayne, K., Suwiwat, S., Byers, S., Marshall, V.R., Tilley, W.D., Horsfall, D.J., Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J. Biol. Chem. 282 (2007), 10814–10825.
125. Ricciardelli, C., Sakko, A.J., Ween, M.P., Russell, D.L., Horsfall, D.J., The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 28 (2009), 233–245.
126. Sato, N., Kohi, S., Hirata, K., Goggins, M., Role of hyaluronan in pancreatic cancer biology and therapy: once again in the spotlight. Cancer Sci. 107 (2016), 569–575.
127. Schwertfeger, K.L., Cowman, M.K., Telmer, P.G., Turley, E.A., McCarthy, J.B., Hyaluronan, inflammation, and breast cancer progression. Front. Immunol., 6, 2015, 236.
128. Narunsky, L., Oren, R., Bochner, F., Neeman, M., Imaging aspects of the tumor stroma with therapeutic implications. Pharmacol. Ther. 141 (2014), 192–208.
129. Dvorak, H.F., Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315 (1986), 1650–1659.
130. Dvorak, H.F., Tumors: wounds that do not heal-redux. Cancer Immunol. Res. 3 (2015), 1–11.
131. Keire, P.A., Bressler, S.L., Mulvihill, E.R., Starcher, B.C., Kang, I., Wight, T.N., Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo. Matrix Biol. 50 (2016), 67–81.
132. Vernon, R.B., Sage, E.H., Between molecules and morphology. Extracellular matrix and creation of vascular form. Am. J. Pathol. 147 (1995), 873–883.
133. Rivera, C.G., Bader, J.S., Popel, A.S., Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins. Ann. Biomed. Eng. 39 (2011), 2213–2222.
134. Zheng, P.S., Wen, J., Ang, L.C., Sheng, W., Viloria-Petit, A., Wang, Y., Wu, Y., Kerbel, R.S., Yang, B.B., Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J. 18 (2004), 754–756.
135. Du, W.W., Yang, W., Yee, A.J., Roles of versican in cancer biology–tumorigenesis, progression and metastasis. Histol. Histopathol. 28 (2013), 701–713.
136. Fu, Y., Nagy, J.A., Brown, L.F., Shih, S.C., Johnson, P.Y., Chan, C.K., Dvorak, H.F., Wight, T.N., Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis. J. Histochem. Cytochem. 59 (2011), 463–473.
137. Feinberg, R.N., Beebe, D.C., Hyaluronate in vasculogenesis. Science 220 (1983), 1177–1179.
138. Montesano, R., Kumar, S., Orci, L., Pepper, M.S., Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab. Investig. 75 (1996), 249–262.
139. Rooney, P., Kumar, S., Ponting, J., Wang, M., The role of hyaluronan in tumor neovascularization (review). Int. J. Cancer 60 (1995), 632–636.
140. Rooney, P., Wang, M., Kumar, P., Kumar, S., Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J. Cell Sci. 105 (1993), 213–218.
141. West, D.C., Hampson, I.N., Arnold, F., Kumar, S., Angiogenesis induced by degradation products of hyaluronic acid. Science 228 (1985), 1324–1326.
142. West, D.C., Kumar, S., The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183 (1989), 179–196.
143. Slevin, M., Krupinski, J., Badimon, L., Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J. Angiogenes. Res., 1, 2009, 4.
144. Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R.C., Kumar, S., Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26 (2007), 58–68.
145. Kreutziger, K.L., Muskheli, V., Johnson, P., Braun, K., Wight, T.N., Murry, C.E., Developing vasculature and stroma in engineered human myocardium. Tissue Eng. Part A 17 (2011), 1219–1228.
146. Ghosh, S., Albitar, L., LeBaron, R., Welch, W.R., Samimi, G., Birrer, M.J., Berkowitz, R.S., Mok, S.C., Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol. Oncol. 119 (2010), 114–120.
147. Labropoulou, V.T., Theocharis, A.D., Ravazoula, P., Perimenis, P., Hjerpe, A., Karamanos, N.K., Kalofonos, H.P., Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours. Histopathology 49 (2006), 582–593.
148. Dvorak, H.F., Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20 (2002), 4368–4380.
149. Koyama, H., Hibi, T., Isogai, Z., Yoneda, M., Fujimori, M., Amano, J., Kawakubo, M., Kannagi, R., Kimata, K., Taniguchi, S., Itano, N., Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am. J. Pathol. 170 (2007), 1086–1099.
150. Nara, Y., Kato, Y., Torii, Y., Tsuji, Y., Nakagaki, S., Goto, S., Isobe, H., Nakashima, N., Takeuchi, J., Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican. Histochem. J. 29 (1997), 21–30.
151. Spinelli, F.M., Vitale, D.L., Demarchi, G., Cristina, C., Alaniz, L., The immunological effect of hyaluronan in tumor angiogenesis. Clin. Transl. Immunol., 4, 2015, e52.
152. Bollyky, P.L., Falk, B.A., Wu, R.P., Buckner, J.H., Wight, T.N., Nepom, G.T., Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4 + CD25 + regulatory T cells. J. Leukoc. Biol. 86 (2009), 567–572.
153. Bollyky, P.L., Lord, J.D., Masewicz, S.A., Evanko, S.P., Buckner, J.H., Wight, T.N., Nepom, G.T., Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4 + CD25 + regulatory T cells. J. Immunol. 179 (2007), 744–747.
154. Bollyky, P.L., Wu, R.P., Falk, B.A., Lord, J.D., Long, S.A., Preisinger, A., Teng, B., Holt, G.E., Standifer, N.E., Braun, K.R., Xie, C.F., Samuels, P.L., Vernon, R.B., Gebe, J.A., Wight, T.N., Nepom, G.T., ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 7938–7943.
155. Evanko, S.P., Potter-Perigo, S., Bollyky, P.L., Nepom, G.T., Wight, T.N., Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 31 (2012), 90–100.
156. Nagy, N., Kaber, G., Johnson, P., Gebe, J., Preisinger, A., Falk, B., Sunkari, V., Gooden, M., Vernon, R., Bogdani, M., Kuipers, H., Day, A., Campbell, D., Wight, T., Bollyky, P., Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J. Clin. Invest. 185 (2015), 372–381.
157. Kuipers, H.F., Rieck, M., Gurevich, I., Nagy, N., Butte, M.J., Negrin, R.S., Wight, T.N., Steinman, L., Bollyky, P.L., Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 1339–1344.
158. de la Motte, C.A., Hascall, V.C., Calabro, A., Yen-Lieberman, B., Strong, S.A., Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J. Biol. Chem 274 (1999), 30747–30755.
159. Evanko, S.P., Potter-Perigo, S., Johnson, P.Y., Wight, T.N., Organization of hyaluronan and versican in the extracellular matrix of human fibroblasts treated with the viral mimetic poly I:C. J. Histochem. Cytochem. 57 (2009), 1041–1060.
160. Hascall, V.C., Majors, A.K., De La Motte, C.A., Evanko, S.P., Wang, A., Drazba, J.A., Strong, S.A., Wight, T.N., Intracellular hyaluronan: a new frontier for inflammation?. Biochim. Biophys. Acta 1673 (2004), 3–12.
161. Selbi, W., de la Motte, C., Hascall, V., Phillips, A., BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J. Am. Soc. Nephrol. 15 (2004), 1199–1211.
162. Wang, A., Hascall, V.C., Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J. Biol. Chem. 279 (2004), 10279–10285.
163. Adair-Kirk, T.L., Senior, R.M., Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40 (2008), 1101–1110.
164. Powell, J.D., Horton, M.R., Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol. Res. 31 (2005), 207–218.
165. Noble, P.W., Jiang, D., Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc. Am. Thorac. Soc. 3 (2006), 401–404.
166. Noble, P.W., McKee, C.M., Cowman, M., Shin, H.S., Hyaluronan fragments activate an NF-κB/I-κBalpha autoregulatory loop in murine macrophages. J. Exp. Med. 183 (1996), 2373–2378.
167. Nandadasa, S., Foulcer, S., Apte, S.S., The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. Matrix Biol. 35 (2014), 34–41.
168. Hope, C., Foulcer, S., Jagodinsky, J., Chen, S.X., Jensen, J.L., Patel, S., Leith, C., Maroulakou, I., Callander, N., Miyamoto, S., Hematti, P., Apte, S.S., Asimakopoulos, F., Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood, 2016.
169. Albeiroti, S., Soroosh, A., de la Motte, C.A., Hyaluronan's role in fibrosis: a pathogenic factor or a passive player?. Biomed. Res. Int., 2015, 2015, 790203.
170. Majors, A.K., Austin, R.C., de la Motte, C.A., Pyeritz, R.E., Hascall, V.C., Kessler, S.P., Sen, G., Strong, S.A., Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J. Biol. Chem. 278 (2003), 47223–47231.
171. Cheng, G., Swaidani, S., Sharma, M., Lauer, M.E., Hascall, V.C., Aronica, M.A., Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol. 30 (2011), 126–134.
172. Cheng, G., Swaidani, S., Sharma, M., Lauer, M.E., Hascall, V.C., Aronica, M.A., Correlation of hyaluronan deposition with infiltration of eosinophils and lymphocytes in a cockroach-induced murine model of asthma. Glycobiology 23 (2013), 43–58.
173. Reeves, S.R., Kaber, G., Sheih, A., Cheng, G., Aronica, M.A., Merrilees, M.J., Debley, J.S., Frevert, C.W., Ziegler, S.F., Wight, T.N., Subepithelial accumulation of versican in a cockroach antigen-induced murine model of allerigic asthma. J. Histochem. Cytochem. 64 (2016), 364–380.
174. Lennon, F.E., Singleton, P.A., Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. Am. J. Physiol. Lung Cell Mol. Physiol. 301 (2011), L137–L147.
175. Gill, S., Wight, T.N., Frevert, C.W., Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat. Rec. (Hoboken) 293 (2010), 968–981.
176. Andersson-Sjoland, A., Hallgren, O., Rolandsson, S., Weitoft, M., Tykesson, E., Larsson-Callerfelt, A.K., Rydell-Tormanen, K., Bjermer, L., Malmstrom, A., Karlsson, J.C., Westergren-Thorsson, G., Versican in inflammation and tissue remodeling: the impact on lung disorders. Glycobiology 25 (2015), 243–251.
177. Selbi, W., de la Motte, C.A., Hascall, V.C., Day, A.J., Bowen, T., Phillips, A.O., Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 70 (2006), 1287–1295.
178. Bogdani, M., Johnson, P.Y., Potter-Perigo, S., Nagy, N., Day, A.J., Bollyky, P.L., Wight, T.N., Hyaluronan and hyaluronan binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes 63 (2014), 2727–2743.
179. Bogdani, M., Korpos, E., Simeonovic, C.J., Parish, C.R., Sorokin, L., Wight, T.N., Extracellular matrix components in the pathogenesis of type 1 diabetes. Curr. Diab. Rep., 14, 2014, 552.
180. Jiang, D., Liang, J., Noble, P.W., Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 91 (2011), 221–264.
181. Lee-Sayer, S.S., Dong, Y., Arif, A.A., Olsson, M., Brown, K.L., Johnson, P., The where, when, how, and why of hyaluronan binding by immune cells. Front. Immunol., 6, 2015, 150.
182. Ruppert, S.M., Hawn, T.R., Arrigoni, A., Wight, T.N., Bollyky, P.L., Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol. Res. 58 (2014), 186–192.
183. Cyphert, J.M., Trempus, C.S., Garantziotis, S., Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int. J. Cell Biol., 2015, 2015, 563818.
184. Bogels, M., Braster, R., Nijland, P.G., Gul, N., van de Luijtgaarden, W., Fijneman, R.J., Meijer, G.A., Jimenez, C.R., Beelen, R.H., van Egmond, M., Carcinoma origin dictates differential skewing of monocyte function. Oncoimmunology 1 (2012), 798–809.
185. Hope, C., Ollar, S.J., Heninger, E., Hebron, E., Jensen, J.L., Kim, J., Maroulakou, I., Miyamoto, S., Leith, C., Yang, D.T., Callander, N., Hematti, P., Chesi, M., Bergsagel, P.L., Asimakopoulos, F., TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood 123 (2014), 3305–3315.
186. Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.L., Karin, M., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457 (2009), 102–106.
187. Li, D., Wang, X., Wu, J.L., Quan, W.Q., Ma, L., Yang, F., Wu, K.Y., Wan, H.Y., Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. PLoS One, 8, 2013, e56616.
188. Said, N., Sanchez-Carbayo, M., Smith, S.C., Theodorescu, D., RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. J. Clin. Invest. 122 (2012), 1503–1518.
189. Said, N., Theodorescu, D., RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment. Oncoimmunology 1 (2012), 1175–1177.
190. Tang, M., Diao, J., Gu, H., Khatri, I., Zhao, J., Cattral, M.S., Toll-like receptor 2 activation promotes tumor dendritic cell dysfunction by regulating IL-6 and IL-10 receptor signaling. Cell Rep. 13 (2015), 2851–2864.
191. Wang, W., Xu, G.L., Jia, W.D., Ma, J.L., Li, J.S., Ge, Y.S., Ren, W.H., Yu, J.H., Liu, W.B., Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch. Med. Res. 40 (2009), 321–323.
192. Zhang, Z., Miao, L., Wang, L., Inflammation amplification by versican: the first mediator. Int. J. Mol. Sci. 13 (2012), 6873–6882.
193. Clark, R.A.F., Henson, P.M., The Molecular and Cellular Biology of Wound Repair. 1988, Plenum Press, New York.
194. Gabbiani, G., The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200 (2003), 500–503.
195. Hinz, B., Gabbiani, G., Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol. Rep., 2, 2010, 78.
196. Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C., Brown, R.A., Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3 (2002), 349–363.
197. Jenkins, R.H., Thomas, G.J., Williams, J.D., Steadman, R., Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J. Biol. Chem. 279 (2004), 41453–41460.
198. Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A., Steadman, R., Involvement of hyaluronan in regulation of fibroblast phenotype. J. Biol. Chem. 282 (2007), 25687–25697.
199. Meran, S., Thomas, D.W., Stephens, P., Enoch, S., Martin, J., Steadman, R., Phillips, A.O., Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J. Biol. Chem. 283 (2008), 6530–6545.
200. Simpson, R.M., Meran, S., Thomas, D., Stephens, P., Bowen, T., Steadman, R., Phillips, A., Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am. J. Pathol. 175 (2009), 1915–1928.
201. Webber, J., Jenkins, R.H., Meran, S., Phillips, A., Steadman, R., Modulation of TGFβ1-dependent myofibroblast differentiation by hyaluronan. Am. J. Pathol. 175 (2009), 148–160.
202. Webber, J., Meran, S., Steadman, R., Phillips, A., Hyaluronan orchestrates transforming growth factor-β1-dependent maintenance of myofibroblast phenotype. J. Biol. Chem. 284 (2009), 9083–9092.
203. Guo, N., Li, X., Mann, M.M., Funderburgh, M.L., Du, Y., Funderburgh, J.L., Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J. Biol. Chem. 285 (2010), 32012–32019.
204. Ito, T., Williams, J.D., Fraser, D., Phillips, A.O., Hyaluronan attenuates transforming growth factor-β1-mediated signaling in renal proximal tubular epithelial cells. Am. J. Pathol. 164 (2004), 1979–1988.
205. Ito, T., Williams, J.D., Fraser, D.J., Phillips, A.O., Hyaluronan regulates transforming growth factor-β1 receptor compartmentalization. J. Biol. Chem. 279 (2004), 25326–25332.
206. Twarock, S., Tammi, M.I., Savani, R.C., Fischer, J.W., Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Biol. Chem. 285 (2010), 23276–23284.
207. Allison, D.D., Wight, T.N., Ripp, N.J., Braun, K.R., Grande-Allen, K.J., Endogenous overexpression of hyaluronan synthases within dynamically cultured collagen gels: implications for vascular and valvular disease. Biomaterials 29 (2008), 2969–2976.
208. Grinnell, F., Zhu, M., Carlson, M.A., Abrams, J.M., Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp. Cell Res. 248 (1999), 608–619.
209. Hinz, B., Gabbiani, G., Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14 (2003), 538–546.
210. Li, Y., Jiang, D., Liang, J., Meltzer, E.B., Gray, A., Miura, R., Wogensen, L., Yamaguchi, Y., Noble, P.W., Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J. Exp. Med. 208 (2011), 1459–1471.
211. Li, Y., Liang, J., Yang, T., Monterrosa Mena, J., Huan, C., Xie, T., Kurkciyan, A., Liu, N., Jiang, D., Noble, P.W., Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis. Matrix Biol. 55 (2016), 35–48.
212. Evanko, S.P., Potter-Perigo, S., Petty, L.J., Workman, G.A., Wight, T.N., Hyaluronan controls the deposition of fibronectin and collagen and modulates TGF-beta1 induction of lung myofibroblasts. Matrix Biol. 42 (2015), 74–92.
213. Carthy, J.M., Meredith, A.J., Boroomand, S., Abraham, T., Luo, Z., Knight, D., McManus, B.M., Versican V1 overexpression induces a myofibroblast-like phenotype in cultured fibroblasts. PLoS One, 10, 2015, e0133056.